| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.52 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |